Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Lactobacillus Reuteri DSM 17938 to Prevent Antibiotic-associated Diarrhea in Children: Prospective, Multi-center, Randomize, Parallel Group Placebo Controlled Clinical Trial

NCT02765217 is registered in ClinicalTrials.gov with Eskisehir Osmangazi University as lead sponsor.

NCT NCT02765217
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02765217 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Lactobacillus Reuteri DSM 17938 to Prevent Antibiotic-associated Diarrhea in Children: Prospective, Multi-center, Randomize, Parallel Group Placebo Controlled Clinical Trial
Lead sponsor
Eskisehir Osmangazi University
Phase
Phase 4
Overall status
Completed
Start date
June 1, 2017
Completion date
December 1, 2020
Enrollment
1,325 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

antibiotic associated diarrhea